prazitel 230/20 mg
chanelle pharmaceuticals manufacturing ltd., Īrija - praziquantelum, pyranteli embonas - aromatizētas apvalkotās tabletes - kaķi
nobivac rl suspensija injekcijām
intervet international b.v., nīderlande - inactivated rabies virus strain pasteur riv, leptospira interrogans, serogroup canicola, serovar portland-vere, strain ca-12-000, inactivated, leptospira interrogans, serogroup icterohaemorrhagiae, serovar copenhageni, strain 820k, inactivated - suspensija injekcijām - suņi
nobilis ib+g+nd ūdens-eļļas emulsija injekcijai
intervet international b.v., nīderlande - inaktivēta infekcijas, bronhīts vīrusu serotipu massachusetts, celms m41,inaktivēta Ņūkāslas slimības vīruss, celms klons 30,inaktivēta infekcijas bursal slimības vīruss, celms, d78 - ūdens-eļļas emulsija injekcijai - vistas
sedalin gel 35 mg/ml gels iekšķīgai lietošanai
vetoquinol biowet sp. z o.o., polija - acepromazīns (kā maleāts) - gels iekšķīgai lietošanai - 35 mg/ml - suņi; zirgi
canigen pi/l
virbac, francija - inaktivēta leptospira lūdzot serogrupas icterohaemorrhagiae serovārs icterohaemorrhagiae, celms 601895, inaktivēta leptospira lūdzot serogrupas canicola serovārs canicola, celms 601903, suņu parainfluenza vīruss, celmu manhattan - liofilizāts un suspensija suspensijas injekcijām pagatavošanai - suņi
bioequin ft suspensija injekcijām
bioveta, ,a.s., Čehija - inaktivēta zirgu gripas vīruss, celms, a/equi 2/brno 08 (amerikas tips) h3n8, inaktivēta zirgu gripas vīruss, celms, a/equi 2/ morāvas 95 (eiropas tipa) h3n8, tetanus toxoid - suspensija injekcijām - zirgi
purevax rcp
boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals par kaķveidīgo, - kaķi - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.
nobilis influenza h5n2
intervet international bv - inaktivēta visu putnu gripas vīrusa antigēna (h5n2 apakštipa (celms a/pīļu/potsdam/1402/86) - imunoloģisks aves - cālis - cāļu aktīvai imunizācijai pret putnu gripu a tipa h5 apakštipam. efektivitāte ir novērtēta, pamatojoties uz sākotnējiem rezultātiem cāļiem. klīnisko pazīmju, mirstības un vīrusa izdalīšanās pēc izaicinājuma samazināšana tika parādīta trīs nedēļas pēc vakcinācijas. paredzams, ka seruma antivielas saglabāsies vismaz 12 mēnešus pēc divu vakcīnas devu ievadīšanas.
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals par kaķveidīgo, - kaķi - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals par kaķveidīgo, - kaķi - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.